Collagenase mRNA Overexpression and Decreased Extracellular Matrix Components Are Early Events in the Pathogenesis of Emphysema

Carregando...
Imagem de Miniatura
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Citação
PLOS ONE, v.10, n.6, article ID e0129590, 16p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
To describe the progression of parenchymal remodeling and metalloproteinases gene expression in earlier stages of emphysema, mice received porcine pancreatic elastase (PPE) instillation and Control groups received saline solution. After PPE instillation (1, 3, 6 hours, 3 and 21 days) we measured the mean linear intercept, the volume proportion of types I and III collagen, elastin, fibrillin and the MMP-1, -8, -12 and -13 gene expression. We observed an initial decrease in type I (at the 3rd day) and type III collagen (from the 6th hour until the 3rd day), in posterior time points in which we detected increased gene expression for MMP-8 and -13 in PPE groups. After 21 days, the type III collagen fibers increased and the type I collagen values returned to similar values compared to control groups. The MMP-12 gene expression was increased in earlier times (3 and 6 hours) to which we detected a reduced proportion of elastin (3 days) in PPE groups, reinforcing the already established importance of MMP-12 in the breakdown of ECM. Such findings will be useful to better elucidate the alterations in ECM components and the importance of not only metalloelastase but also collagenases in earlier emphysema stages, providing new clues to novel therapeutic targets.
Palavras-chave
Referências
  1. Abraham T, 2000, J STRUCT BIOL, V171, P189
  2. ABRAMS WR, 1988, EXP LUNG RES, V14, P459, DOI 10.3109/01902148809087821
  3. Anciaes AM, 2011, CLINICS, V66, P1797, DOI 10.1590/S1807-59322011001000020
  4. Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171
  5. Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703
  6. Betsuyaku T, 1999, AM J RESP CRIT CARE, V159, P1985
  7. Cavarra E, 1996, LAB INVEST, V75, P273
  8. Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-5110C
  9. Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353
  10. Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611
  11. DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O
  12. Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240
  13. GOLD, 2014, GLOB STRAT DIAGN MAN
  14. Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002
  15. Imai K, 2001, AM J RESP CRIT CARE, V163, P786
  16. Ito S, 2005, J APPL PHYSIOL, V98, P503, DOI 10.1152/japplphysiol.00590.2004
  17. Kawakami M, 2008, BIOL PHARM BULL, V31, P1434, DOI 10.1248/bpb.31.1434
  18. Koenders MMJF, 2009, J PATHOL, V218, P446, DOI 10.1002/path.2548
  19. Kononov S, 2001, AM J RESP CRIT CARE, V164, P1920
  20. KUHN C, 1976, LAB INVEST, V34, P372
  21. Kurimoto E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-5
  22. LANG MR, 1994, THORAX, V49, P319, DOI 10.1136/thx.49.4.319
  23. Lee EJ, 2009, CHEST, V135, P344, DOI 10.1378/chest.08-1583
  24. Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
  25. Lourenco JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098216
  26. Lucey EC, 1998, AM J RESP CRIT CARE, V158, P555
  27. MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391
  28. Ramos DS, 2010, MED SCI SPORT EXER, V42, P113, DOI 10.1249/MSS.0b013e3181ad1c72
  29. Goncalves CTR, 2012, CRIT CARE, V16, DOI 10.1186/cc11807
  30. Rubio ML, 2004, CHEST, V125, P1500, DOI 10.1378/chest.125.4.1500
  31. Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684
  32. Shapiro SD, 1999, AM J RESP CELL MOL, V20, P1100
  33. SHAPIRO SD, 1994, AM J RESP CRIT CARE, V150, pS160
  34. Shifren A, 2007, AM J PHYSIOL-LUNG C, V292, pL778, DOI 10.1152/ajplung.00352.2006
  35. Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW
  36. Shiomi T, 2003, EXP LUNG RES, V29, P1, DOI 10.1080/01902140390116526
  37. Silver FH, 2002, J THEOR BIOL, V216, P243, DOI 10.1006/jtbi.2002.2542
  38. SNIDER GL, 1988, AM REV RESPIR DIS, V137, P918
  39. SNIDER GL, 1986, AM REV RESPIR DIS, V133, P149
  40. Spiess K, 2007, CONNECT TISSUE RES, V48, P99, DOI 10.1080/03008200601166194
  41. Stockley RA, 2001, NOVART FDN SYMP, V234, P189
  42. STOLK J, 1992, J PATHOL, V167, P349, DOI 10.1002/path.1711670314
  43. STONE PJ, 1995, AM J RESP CRIT CARE, V151, P952
  44. Suki B, 2011, COMPR PHYSIOL, V1, P1317, DOI 10.1002/cphy.c100033
  45. Suki B, 2008, RESP PHYSIOL NEUROBI, V163, P33, DOI 10.1016/j.resp.2008.03.015
  46. Takubo Y, 2002, AM J RESP CRIT CARE, V166, P1596, DOI 10.1164/rccm.2202001
  47. Vieira RD, 2012, MED SCI SPORT EXER, V44, P1227, DOI 10.1249/MSS.0b013e31824b2877
  48. Vlahovic G, 1999, AM J RESP CRIT CARE, V160, P2086
  49. WEIBEL ER, 1963, LAB INVEST, V12, P131